Clinical Trial Update: A Study Comparing Tazarotene Cream 0.05% to TAZORAC® (Tazarotene) Cream 0.05% and Both to a Placebo Control in the Treatment of Plaque Psoriasis [Phase 3]

View source ↗

Summary

A Phase 3 trial comparing tazarotene 0.05% cream to TAZORAC® (tazarotene) 0.05% cream and to placebo in plaque psoriasis has completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• TAZORAC® (Tazarotene) Cream 0.05% (tazarotene)
• Tazarotene Cream 0.05% (tazarotene)

Snippet

Sponsor: Fougera Pharmaceuticals Inc. | Conditions: Plaque Psoriasis | Phase 3 | Status: COMPLETED | Results posted: 2018-08-29